Global Deep Brain Stimulation in Parkinson’s Diseases Market (By Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), By End User (Hospitals, Research Center, Neurology Clinics, Ambulatory Surgical Centers))- Prospective Landscape, Size, Share, Growth, Opportunities and Industry Forecast 2019-2028

Published DateReport CodeNo. of PagesReport Format
July – 2020AMR- 9024110PDF / Excel

SelectLicense Type

The global analysis provides an exhaustive investigation of the global deep brain stimulation in parkinson’s diseases market which sheds light on future projections to assess the investment feasibility of the global market. Furthermore, the report incorporates both quantitative and qualitative research methodologies for getting better insights on the global market scenario. The innovative research report also comprehends the global business opportunities and scope for expansion of the deep brain stimulation in parkinson’s diseases market across the world.

This report entails a detailed quantitative analysis that offers the recent key developments and latest technological advancements from 2020 to 2028 to identify the prevailing opportunities across the global region. Moreover, the increasing incidence of Parkinson’s disease across the developing and developed countries is driving the new product launches in the market. The increasing availability of other treatment options such as drug therapies and surgeries hinder the growth of the deep brain stimulation devices market. Increasing prevalence of diseases such as depression, chronic pain, and rising number of neurological disorders are the factors that drive the global market growth.

Market Insights

Alchemy Market Research proclaims the addition of new innovative report on the global Deep Brain Stimulation in Parkinson’s Diseases Market to its massive database. The global Deep Brain Stimulation in Parkinson’s Diseases market size was estimated at USD 740 million in 2020 and is relied upon to enlist a CAGR 8.7 % over the estimated time frame 2020-2028. Furthermore, this research report offers detailed premium insights into the global Deep Brain Stimulation in Parkinson’s Diseases market and reveals global revenue generation, financial aspects, and commercial prospects of the market. This global research report is an intelligence report with a meticulous and reliable data of the global market statistics. Different key variables and regression models have been used to calculate the trajectory of the Deep Brain Stimulation in Parkinson’s Diseases market. Different economic aspects of the global market are incorporated in the report to outline the financial perspectives of the businesses. An expert team of researcher’s sheds light on current and futuristic growth opportunities across the global regions.

Alchemy Market Research directs its focus on some significant factors to give a gist about the scope and demands for this global market. Different drivers and restraints have been presented to get better insights about the ups and downs of the businesses. This intelligence report presents the 360-degree overview of the competitive and regional outlook of the global Deep Brain Stimulation in Parkinson’s Diseases market.

The rising product innovation and increasing product development by leading manufacturers are fueling global market growth. Expert views, opinions, and recommendations by neurologists are further leading the global market growth over the forecast period. The supportive government policies and regulations initiated by several countries are driving the global market growth. Moreover, the aging population across the emerging economies prone to Parkinson’s disease. The notable technological advancements in deep brain stimulator devices such as MRI, multi-target stimulation, personalized directed programming are expected to raise the global deep brain stimulators over the forecast timeframe. Furthermore, different leading key companies integrating innovative technologies into the stimulators to treat the diseases. High prevalence of neurological disorders in the global countries such as U.S and Canada has boosted the global market growth. From the last few years, increase in government funding and awareness programs about Parkinson’s disease are escalating the global market growth. The National Institute of Neurological Disorder and Stroke supporting the research and development programs for determining the effectiveness of the treatment.

Regional Insights

  • The increasing prevalence of psychological disorders, increasing concerns about health treatments, availability of professional physicians, and technological advancements in the healthcare sector are some important factors for fueling the global market in North America. The increasing R&D activities and rising availability of deep brain stimulation devices are also creating the array of opportunities in the global market.
  • Furthermore, innovative devices and surgical procedures in the global deep brain stimulating market are also enhancing the global market growth. The increasing prevalence of Parkinson’s disease, growing neurosurgical capabilities, and rising awareness programs are responsible factors behind the growth of the Asia-Pacific market.
  • In addition to this, innovative initiatives by neurosurgeons and neurology clinics for increasing the awareness regarding the deep brain stimulation have resulted in market growth.

Key Industry Development

  • Different manufacturing industries are focusing on research and development to develop advanced products to gain competitive edge in the global market. In January 2020, Abbott’s Infinity DBS system has approved the expansion from the U.S. Food and Drug Administration for the treatment of Parkinson’s diseases.
  • In October 2019, Medtronic has launched the advancements in technologies for the DBS therapy across the US during Samsung Developers Conference.
  • In January 2017, Abbott has acquired St. Jude Medical for strengthening the therapeutic areas.

List of Companies profiled in the report

The massive research repository on global Deep Brain Stimulation in Parkinson’s Diseases Market incorporates the global competitive landscape of the leading manufacturers based on different aspects such as technological advancements, market trends, and global market shares. It offers meticulous data about business acumen and business plans carried out by leading key players to formulate the strategic business methodologies.

Following key players have been profiled in the report:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Functional Neuromodulation Ltd
  • NeuroPace Inc
  • Nevro Corporation
  • Neuronetics Inc
  • Beijing PINS Medical Co
  • Medtronic
  • Aleva Neurotherapeutics SA

Report Scope by Market Segments

The global Deep Brain Stimulation in Parkinson’s Diseases Market fragmented on the basis of different perspectives such as product type, end-user, and global geographies. Different global market segments have been analyzed to get better insights about the market scenario. The global research report analyzing the latest industry trends and global growth opportunities across the global regions.

Deep Brain Stimulation in Parkinson’s Diseases Market Segmentation

Product Perspective (Revenue in USD Million)

  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator

End-User Perspective (Revenue in USD Million)

  • Hospitals
  • Research Center
  • Neurology Clinics
  • Ambulatory Surgical Centers

Regional Perspective: (Revenue in USD Million)

  • North America
    • U.S.A
    • Canada
  • Europe
    • Italy
    • Germany
    • France
    • UK
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

This Report Answers Key Questions Such As

  • What are the recent trends in the global Deep Brain Stimulation in Parkinson’s Diseases market?
  • What is the global market size and market shares over the forecast timeframe?
  • What are the different methodologies for offering plenty of growth opportunities in the global market?
  • Which are the major end-users of the Deep Brain Stimulation in Parkinson’s Diseases Market?
  • What will be the global market statistics and market estimates over the forecast period?
  • Which factors are driving and hampering the global market growth?
  • What are the leading key players of the Deep Brain Stimulation in Parkinson’s Diseases Market?
  • What are the new approach and effective strategies adopted by leading companies to achieve desired outcomes in the market?

Chapter 1. Executive Summary

Chapter 2. Market Introduction

Chapter 3. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028 – Key Industry Dynamics

3.1. Key Market Drivers
3.2. Key Market Restraints
3.3. Market Opportunities
3.4. Future Trends
3.5. Impact Analysis of Drivers and Restraints

Chapter 4. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

Chapter 5. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028 – By Product

5.1. Single Channel Deep Brain Stimulator
5.2. Dual Channel Deep Brain Stimulator

Chapter 6. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028 – By End-User

6.1. Hospitals
6.2. Research Center
6.3. Neurology Clinics
6.4. Ambulatory Surgical Centers

Chapter 7. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028 – By Region

7.1. North America
7.2. Europe
7.3. Asia-Pacific
7.4. Latin America
7.5. Middle East & Africa

Chapter 8. North America Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

8.1. North America Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

8.1.1. Single Channel Deep Brain Stimulator
8.1.2. Dual Channel Deep Brain Stimulator

8.2. North America Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

8.2.1. Hospitals
8.2.2. Research Center
8.2.3. Neurology Clinics
8.2.4. Ambulatory Surgical Centers

8.3. North America Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

8.3.1. U.S.
8.3.2. Canada

Chapter 9. Europe Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

9.1. Europe Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

9.1.1. Single Channel Deep Brain Stimulator
9.1.2. Dual Channel Deep Brain Stimulator

9.2. Europe Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

9.2.1. Hospitals
9.2.2. Research Center
9.2.3. Neurology Clinics
9.2.4. Ambulatory Surgical Centers

9.3. Europe Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

9.3.1. Germany
9.3.2. France
9.3.3. UK
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe

Chapter 10. Asia Pacific Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

10.1. Asia Pacific Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

10.1.1. Single Channel Deep Brain Stimulator
10.1.2. Dual Channel Deep Brain Stimulator

10.2. Asia Pacific Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

10.2.1. Hospitals
10.2.2. Research Center
10.2.3. Neurology Clinics
10.2.4. Ambulatory Surgical Centers

10.3. Asia-Pacific Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Rest of Asia-Pacific

Chapter 11. Latin America Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

11.1. Latin America Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

11.1.1. Single Channel Deep Brain Stimulator
11.1.2. Dual Channel Deep Brain Stimulator

11.2. Latin America Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

11.2.1. Hospitals
11.2.2. Research Center
11.2.3. Neurology Clinics
11.2.4. Ambulatory Surgical Centers

11.3. Latin America Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America

Chapter 12. Middle East & Africa Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

12.1. Middle East & Africa Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

12.1.1. Single Channel Deep Brain Stimulator
12.1.2. Dual Channel Deep Brain Stimulator

12.2. Middle East & Africa Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

12.2.1. Hospitals
12.2.2. Research Center
12.2.3. Neurology Clinics
12.2.4. Ambulatory Surgical Centers

12.3. Middle East & Africa Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

12.3.1. UAE
12.3.2. Saudi Arabia
12.3.3. Turkey
12.3.4. Rest of Middle East & Africa

Chapter 13. Competitive Analysis

13.1.1. Competition Dashboard
13.1.2. Company Profiles

13.1.2.1. Abbott Laboratories
13.1.2.2. Boston Scientific Corporation
13.1.2.3. Functional Neuromodulation Ltd
13.1.2.4. NeuroPace Inc
13.1.2.5. Nevro Corporation
13.1.2.6. Neuronetics Inc
13.1.2.7. Beijing PINS Medical Co
13.1.2.8. Medtronic
13.1.2.9. Aleva Neurotherapeutics SA

Report Synopsis

The global analysis provides an exhaustive investigation of the global deep brain stimulation in parkinson’s diseases market which sheds light on future projections to assess the investment feasibility of the global market. Furthermore, the report incorporates both quantitative and qualitative research methodologies for getting better insights on the global market scenario. The innovative research report also comprehends the global business opportunities and scope for expansion of the deep brain stimulation in parkinson’s diseases market across the world.

This report entails a detailed quantitative analysis that offers the recent key developments and latest technological advancements from 2020 to 2028 to identify the prevailing opportunities across the global region. Moreover, the increasing incidence of Parkinson’s disease across the developing and developed countries is driving the new product launches in the market. The increasing availability of other treatment options such as drug therapies and surgeries hinder the growth of the deep brain stimulation devices market. Increasing prevalence of diseases such as depression, chronic pain, and rising number of neurological disorders are the factors that drive the global market growth.

Report Description

Market Insights

Alchemy Market Research proclaims the addition of new innovative report on the global Deep Brain Stimulation in Parkinson’s Diseases Market to its massive database. The global Deep Brain Stimulation in Parkinson’s Diseases market size was estimated at USD 740 million in 2020 and is relied upon to enlist a CAGR 8.7 % over the estimated time frame 2020-2028. Furthermore, this research report offers detailed premium insights into the global Deep Brain Stimulation in Parkinson’s Diseases market and reveals global revenue generation, financial aspects, and commercial prospects of the market. This global research report is an intelligence report with a meticulous and reliable data of the global market statistics. Different key variables and regression models have been used to calculate the trajectory of the Deep Brain Stimulation in Parkinson’s Diseases market. Different economic aspects of the global market are incorporated in the report to outline the financial perspectives of the businesses. An expert team of researcher’s sheds light on current and futuristic growth opportunities across the global regions.

Alchemy Market Research directs its focus on some significant factors to give a gist about the scope and demands for this global market. Different drivers and restraints have been presented to get better insights about the ups and downs of the businesses. This intelligence report presents the 360-degree overview of the competitive and regional outlook of the global Deep Brain Stimulation in Parkinson’s Diseases market.

The rising product innovation and increasing product development by leading manufacturers are fueling global market growth. Expert views, opinions, and recommendations by neurologists are further leading the global market growth over the forecast period. The supportive government policies and regulations initiated by several countries are driving the global market growth. Moreover, the aging population across the emerging economies prone to Parkinson’s disease. The notable technological advancements in deep brain stimulator devices such as MRI, multi-target stimulation, personalized directed programming are expected to raise the global deep brain stimulators over the forecast timeframe. Furthermore, different leading key companies integrating innovative technologies into the stimulators to treat the diseases. High prevalence of neurological disorders in the global countries such as U.S and Canada has boosted the global market growth. From the last few years, increase in government funding and awareness programs about Parkinson’s disease are escalating the global market growth. The National Institute of Neurological Disorder and Stroke supporting the research and development programs for determining the effectiveness of the treatment.

Regional Insights

  • The increasing prevalence of psychological disorders, increasing concerns about health treatments, availability of professional physicians, and technological advancements in the healthcare sector are some important factors for fueling the global market in North America. The increasing R&D activities and rising availability of deep brain stimulation devices are also creating the array of opportunities in the global market.
  • Furthermore, innovative devices and surgical procedures in the global deep brain stimulating market are also enhancing the global market growth. The increasing prevalence of Parkinson’s disease, growing neurosurgical capabilities, and rising awareness programs are responsible factors behind the growth of the Asia-Pacific market.
  • In addition to this, innovative initiatives by neurosurgeons and neurology clinics for increasing the awareness regarding the deep brain stimulation have resulted in market growth.

Key Industry Development

  • Different manufacturing industries are focusing on research and development to develop advanced products to gain competitive edge in the global market. In January 2020, Abbott’s Infinity DBS system has approved the expansion from the U.S. Food and Drug Administration for the treatment of Parkinson’s diseases.
  • In October 2019, Medtronic has launched the advancements in technologies for the DBS therapy across the US during Samsung Developers Conference.
  • In January 2017, Abbott has acquired St. Jude Medical for strengthening the therapeutic areas.

List of Companies profiled in the report

The massive research repository on global Deep Brain Stimulation in Parkinson’s Diseases Market incorporates the global competitive landscape of the leading manufacturers based on different aspects such as technological advancements, market trends, and global market shares. It offers meticulous data about business acumen and business plans carried out by leading key players to formulate the strategic business methodologies.

Following key players have been profiled in the report:

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Functional Neuromodulation Ltd
  • NeuroPace Inc
  • Nevro Corporation
  • Neuronetics Inc
  • Beijing PINS Medical Co
  • Medtronic
  • Aleva Neurotherapeutics SA

Report Scope by Market Segments

The global Deep Brain Stimulation in Parkinson’s Diseases Market fragmented on the basis of different perspectives such as product type, end-user, and global geographies. Different global market segments have been analyzed to get better insights about the market scenario. The global research report analyzing the latest industry trends and global growth opportunities across the global regions.

Deep Brain Stimulation in Parkinson’s Diseases Market Segmentation

Product Perspective (Revenue in USD Million)

  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator

End-User Perspective (Revenue in USD Million)

  • Hospitals
  • Research Center
  • Neurology Clinics
  • Ambulatory Surgical Centers

Regional Perspective: (Revenue in USD Million)

  • North America
    • U.S.A
    • Canada
  • Europe
    • Italy
    • Germany
    • France
    • UK
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Turkey
    • Rest of Middle East & Africa

This Report Answers Key Questions Such As

  • What are the recent trends in the global Deep Brain Stimulation in Parkinson’s Diseases market?
  • What is the global market size and market shares over the forecast timeframe?
  • What are the different methodologies for offering plenty of growth opportunities in the global market?
  • Which are the major end-users of the Deep Brain Stimulation in Parkinson’s Diseases Market?
  • What will be the global market statistics and market estimates over the forecast period?
  • Which factors are driving and hampering the global market growth?
  • What are the leading key players of the Deep Brain Stimulation in Parkinson’s Diseases Market?
  • What are the new approach and effective strategies adopted by leading companies to achieve desired outcomes in the market?
Table of Content

Chapter 1. Executive Summary

Chapter 2. Market Introduction

Chapter 3. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028 – Key Industry Dynamics

3.1. Key Market Drivers
3.2. Key Market Restraints
3.3. Market Opportunities
3.4. Future Trends
3.5. Impact Analysis of Drivers and Restraints

Chapter 4. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

Chapter 5. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028 – By Product

5.1. Single Channel Deep Brain Stimulator
5.2. Dual Channel Deep Brain Stimulator

Chapter 6. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028 – By End-User

6.1. Hospitals
6.2. Research Center
6.3. Neurology Clinics
6.4. Ambulatory Surgical Centers

Chapter 7. Global Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028 – By Region

7.1. North America
7.2. Europe
7.3. Asia-Pacific
7.4. Latin America
7.5. Middle East & Africa

Chapter 8. North America Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

8.1. North America Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

8.1.1. Single Channel Deep Brain Stimulator
8.1.2. Dual Channel Deep Brain Stimulator

8.2. North America Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

8.2.1. Hospitals
8.2.2. Research Center
8.2.3. Neurology Clinics
8.2.4. Ambulatory Surgical Centers

8.3. North America Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

8.3.1. U.S.
8.3.2. Canada

Chapter 9. Europe Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

9.1. Europe Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

9.1.1. Single Channel Deep Brain Stimulator
9.1.2. Dual Channel Deep Brain Stimulator

9.2. Europe Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

9.2.1. Hospitals
9.2.2. Research Center
9.2.3. Neurology Clinics
9.2.4. Ambulatory Surgical Centers

9.3. Europe Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

9.3.1. Germany
9.3.2. France
9.3.3. UK
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe

Chapter 10. Asia Pacific Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

10.1. Asia Pacific Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

10.1.1. Single Channel Deep Brain Stimulator
10.1.2. Dual Channel Deep Brain Stimulator

10.2. Asia Pacific Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

10.2.1. Hospitals
10.2.2. Research Center
10.2.3. Neurology Clinics
10.2.4. Ambulatory Surgical Centers

10.3. Asia-Pacific Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Rest of Asia-Pacific

Chapter 11. Latin America Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

11.1. Latin America Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

11.1.1. Single Channel Deep Brain Stimulator
11.1.2. Dual Channel Deep Brain Stimulator

11.2. Latin America Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

11.2.1. Hospitals
11.2.2. Research Center
11.2.3. Neurology Clinics
11.2.4. Ambulatory Surgical Centers

11.3. Latin America Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America

Chapter 12. Middle East & Africa Deep Brain Stimulation in Parkinson’s Diseases Market– Analysis and Revenue Forecast 2019-2028

12.1. Middle East & Africa Deep Brain Stimulation in Parkinson’s Diseases Market– By Product

12.1.1. Single Channel Deep Brain Stimulator
12.1.2. Dual Channel Deep Brain Stimulator

12.2. Middle East & Africa Deep Brain Stimulation in Parkinson’s Diseases Market– By End User

12.2.1. Hospitals
12.2.2. Research Center
12.2.3. Neurology Clinics
12.2.4. Ambulatory Surgical Centers

12.3. Middle East & Africa Deep Brain Stimulation in Parkinson’s Diseases Market– By Country

12.3.1. UAE
12.3.2. Saudi Arabia
12.3.3. Turkey
12.3.4. Rest of Middle East & Africa

Chapter 13. Competitive Analysis

13.1.1. Competition Dashboard
13.1.2. Company Profiles

13.1.2.1. Abbott Laboratories
13.1.2.2. Boston Scientific Corporation
13.1.2.3. Functional Neuromodulation Ltd
13.1.2.4. NeuroPace Inc
13.1.2.5. Nevro Corporation
13.1.2.6. Neuronetics Inc
13.1.2.7. Beijing PINS Medical Co
13.1.2.8. Medtronic
13.1.2.9. Aleva Neurotherapeutics SA

Report Methodology
Report Customization
Report Sample
Consult the Analyst